Literature DB >> 22952242

Suppressor of cytokine signaling 6 (SOCS6) negatively regulates Flt3 signal transduction through direct binding to phosphorylated tyrosines 591 and 919 of Flt3.

Julhash U Kazi1, Jianmin Sun, Bengt Phung, Fahad Zadjali, Amilcar Flores-Morales, Lars Rönnstrand.   

Abstract

The receptor tyrosine kinase Flt3 is an important growth factor receptor in hematopoiesis, and gain-of-function mutations of the receptor contribute to the transformation of acute myeloid leukemia. SOCS6 (suppressor of cytokine signaling 6) is a member of the SOCS family of E3 ubiquitin ligases that can regulate receptor tyrosine kinase signal transduction. In this study, we analyzed the role of SOCS6 in Flt3 signal transduction. The results show that ligand stimulation of Flt3 can induce association of SOCS6 and Flt3 and tyrosine phosphorylation of SOCS6. Phosphopeptide fishing indicated that SOCS6 binds directly to phosphotyrosines 591 and 919 of Flt3. By using stably transfected Ba/F3 cells with Flt3 and/or SOCS6, we show that the presence of SOCS6 can enhance ubiquitination of Flt3, as well as internalization and degradation of the receptor. The presence of SOCS6 also induces weaker activation of Erk1/2, but not Akt, in transfected Ba/F3 and UT-7 cells and in OCI-AML-5 cells. The absence of SOCS6 promotes Ba/F3 and UT-7 cell proliferation induced by oncogenic internal tandem duplications of Flt3. Taken together, these results suggest that SOCS6 negatively regulates Flt3 activation, the downstream Erk signaling pathway, and cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22952242      PMCID: PMC3476316          DOI: 10.1074/jbc.M112.376111

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Src family kinases are involved in the differential signaling from two splice forms of c-Kit.

Authors:  Olexandr Voytyuk; Johan Lennartsson; Akira Mogi; Georgina Caruana; Sara Courtneidge; Leonie K Ashman; Lars Rönnstrand
Journal:  J Biol Chem       Date:  2003-01-02       Impact factor: 5.157

2.  Structural basis for c-KIT inhibition by the suppressor of cytokine signaling 6 (SOCS6) ubiquitin ligase.

Authors:  Fahad Zadjali; Ashley C W Pike; Mattias Vesterlund; Jianmin Sun; Chenggang Wu; Shawn S C Li; Lars Rönnstrand; Stefan Knapp; Alex N Bullock; Amilcar Flores-Morales
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

3.  Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.

Authors:  Y Yamamoto; H Kiyoi; Y Nakano; R Suzuki; Y Kodera; S Miyawaki; N Asou; K Kuriyama; F Yagasaki; C Shimazaki; H Akiyama; K Saito; M Nishimura; T Motoji; K Shinagawa; A Takeshita; H Saito; R Ueda; R Ohno; T Naoe
Journal:  Blood       Date:  2001-04-15       Impact factor: 22.113

4.  Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance.

Authors:  R A Mooney; J Senn; S Cameron; N Inamdar; L M Boivin; Y Shang; R W Furlanetto
Journal:  J Biol Chem       Date:  2001-05-07       Impact factor: 5.157

5.  SOCS-6 negatively regulates T cell activation through targeting p56lck to proteasomal degradation.

Authors:  Young Bong Choi; Myoungsun Son; Mijin Park; Jaekyoon Shin; Yungdae Yun
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

6.  Escape from Cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases.

Authors:  Pascal Peschard; Morag Park
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

7.  SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation.

Authors:  Danielle L Krebs; Rachel T Uren; Donald Metcalf; Steven Rakar; Jian-Guo Zhang; Robyn Starr; David P De Souza; Kathy Hanzinikolas; Jo Eyles; Lisa M Connolly; Richard J Simpson; Nicos A Nicola; Sandra E Nicholson; Manuel Baca; Douglas J Hilton; Warren S Alexander
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

8.  Oncogenic Flt3 receptors display different specificity and kinetics of autophosphorylation.

Authors:  Elena Razumovskaya; Kristina Masson; Rasheed Khan; Susanne Bengtsson; Lars Rönnstrand
Journal:  Exp Hematol       Date:  2009-05-27       Impact factor: 3.084

Review 9.  Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3.

Authors:  Kristina Masson; Lars Rönnstrand
Journal:  Cell Signal       Date:  2009-06-18       Impact factor: 4.315

Review 10.  Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications.

Authors:  Shinichiro Takahashi
Journal:  J Hematol Oncol       Date:  2011-04-01       Impact factor: 17.388

View more
  37 in total

1.  The basic helix-loop-helix (bHLH) proteins in breast cancer progression.

Authors:  Nuzhat N Kabir; Lars Rönnstrand; Julhash U Kazi
Journal:  Med Oncol       Date:  2013-07-23       Impact factor: 3.064

Review 2.  Protein kinase C (PKC) as a drug target in chronic lymphocytic leukemia.

Authors:  Julhash U Kazi; Nuzhat N Kabir; Lars Rönnstrand
Journal:  Med Oncol       Date:  2013-10-31       Impact factor: 3.064

Review 3.  Grb10 is a dual regulator of receptor tyrosine kinase signaling.

Authors:  Nuzhat N Kabir; Julhash U Kazi
Journal:  Mol Biol Rep       Date:  2014-01-14       Impact factor: 2.316

4.  Suppressor of cytokine signaling 2 (SOCS2) associates with FLT3 and negatively regulates downstream signaling.

Authors:  Julhash U Kazi; Lars Rönnstrand
Journal:  Mol Oncol       Date:  2013-03-19       Impact factor: 6.603

Review 5.  FLT3-ITD and its current role in acute myeloid leukaemia.

Authors:  Francisco Alejandro Lagunas-Rangel; Venice Chávez-Valencia
Journal:  Med Oncol       Date:  2017-05-03       Impact factor: 3.064

6.  SOCS proteins in development and disease.

Authors:  Monique C Trengove; Alister C Ward
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

7.  Retinal Axon Guidance Requires Integration of Eya and the Jak/Stat Pathway into Phosphotyrosine-Based Signaling Circuitries in Drosophila.

Authors:  Charlene S L Hoi; Wenjun Xiong; Ilaria Rebay
Journal:  Genetics       Date:  2016-05-18       Impact factor: 4.562

8.  FLT3 signals via the adapter protein Grb10 and overexpression of Grb10 leads to aberrant cell proliferation in acute myeloid leukemia.

Authors:  Julhash U Kazi; Lars Rönnstrand
Journal:  Mol Oncol       Date:  2012-11-29       Impact factor: 6.603

9.  Deregulation of protein phosphatase expression in acute myeloid leukemia.

Authors:  Nuzhat N Kabir; Lars Rönnstrand; Julhash U Kazi
Journal:  Med Oncol       Date:  2013-02-26       Impact factor: 3.064

Review 10.  SOCS6 is a selective suppressor of receptor tyrosine kinase signaling.

Authors:  Nuzhat N Kabir; Jianmin Sun; Lars Rönnstrand; Julhash U Kazi
Journal:  Tumour Biol       Date:  2014-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.